Cord blood harvested from At-Risk newborns to fuel sickle cell lab studies
NCT ID NCT03876821
First seen Nov 18, 2025 · Last updated Jun 16, 2026 · Updated 23 times
Summary
This study collected umbilical cord blood from 44 newborns whose mothers carry the sickle cell trait. The goal was to gather cells for laboratory experiments to better understand the disease and develop ways to modify and preserve these cells. No treatments were given; this was purely for research purposes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHSF
Corbeil-Essonnes, 91106, France
Conditions
Explore the condition pages connected to this study.